MedTrace Logo

A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter

NCT06030271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-09-08

No results posted yet for this study

Summary

The trial is a pivotal clinical investigation, which is a prospective, non-randomized pivotal clinical investigation to demonstrate the safety and performance of the TrueCross Single-use Microcatheter.

Conditions

  • Coronary Artery Disease Obliterative
  • Chronic Total Occlusion (CTO)

Interventions

DEVICE

Microcatheter

Support and facilitate the placement of the guidewire in the coronary artery with a CTO.

Sponsors & Collaborators

  • Insight Lifetech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-13
Primary Completion
2023-03-30
Completion
2023-03-30

Countries

  • Georgia
  • Greece
  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06030271 on ClinicalTrials.gov